Relay Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-74.4M | $-77.9M | $3.5M | $48.5M |
| FY2022 | $-229.5M | $-238.6M | $9.1M | $56.1M |
| FY2023 | $-300.3M | $-304.4M | $4.1M | $86.0M |
| FY2024 | $-249.1M | $-251.1M | $2.0M | $94.1M |
| FY2025 | $-235.5M | $-235.9M | $410.0K | $62.4M |